Davis Alan K, Bonar Erin E, Ilgen Mark A, Walton Maureen A, Perron Brian E, Chermack Stephen T
Department of Psychology, Bowling Green State University, 822 E. Merry Ave, Bowling Green, OH 43403, USA; HSR&D Center for Clinical Management Research (CCMR), VA Ann Arbor Healthcare System, 2800 Plymouth Road, Building 16, Floor 2, Ann Arbor, MI 48109, USA.
University of Michigan Addiction Center, Department of Psychiatry, University of Michigan School of Medicine, 4250 Plymouth Road, Ann Arbor, MI 48109, USA.
Addict Behav. 2016 Dec;63:132-6. doi: 10.1016/j.addbeh.2016.07.006. Epub 2016 Jul 8.
Psychiatric symptoms, somatic problems, and co-occurring substance use have been associated with medical marijuana consumption among civilian patients with substance use disorders. It is possible that these factors may impact Veterans' ability to engage in or adhere to mental health and substance use disorder treatment. Therefore, we examined whether psychiatric functioning, substance use, and somatic problems were associated with medical marijuana use among Veterans receiving substance use disorder and/or mental health treatment. Participants (n=841) completed screening measures for a randomized controlled trial and 67 (8%) reported that they had a current medical marijuana card. Most of these participants (78%) reported using marijuana to treat severe/chronic pain. Significant bivariate differences revealed that, compared to participants without a medical marijuana card, those with a card were more likely to be in a middle income bracket, unemployed, and they had a significantly higher number of recent days of marijuana use, synthetic marijuana use, and using sedatives prescribed to them. Additionally, a significantly higher proportion of participants with a medical marijuana card scored above the clinical cutoff for posttraumatic stress disorder (PTSD) symptoms, had significantly higher severity of sleep-related problems, and reported a higher level of pain. These findings highlight the co-occurrence of substance use, PTSD symptoms, sleep-related problems, and chronic pain among Veterans who use medical marijuana. Future research should investigate the inter-relationships among medical marijuana use and other clinical issues (e.g., PTSD symptoms, sleep, pain) over time, and potential implications of medical marijuana use on treatment engagement and response.
在患有物质使用障碍的 civilian 患者中，精神症状、躯体问题以及同时出现的物质使用与医用大麻的消费有关。这些因素可能会影响退伍军人参与或坚持心理健康和物质使用障碍治疗的能力。因此，我们研究了在接受物质使用障碍和/或心理健康治疗的退伍军人中，精神功能、物质使用和躯体问题是否与医用大麻的使用有关。参与者（n = 841）完成了一项随机对照试验的筛查措施，67 人（8%）报告他们目前持有医用大麻卡。这些参与者中的大多数（78%）报告使用大麻来治疗严重/慢性疼痛。显著的双变量差异表明，与没有医用大麻卡的参与者相比，持有卡的参与者更有可能处于中等收入阶层、失业，并且他们最近使用大麻、合成大麻以及使用给他们开的镇静剂的天数明显更多。此外，持有医用大麻卡的参与者中，创伤后应激障碍（PTSD）症状得分高于临床临界值的比例显著更高，睡眠相关问题的严重程度显著更高，并且报告的疼痛程度更高。这些发现突出了使用医用大麻的退伍军人中物质使用、PTSD 症状、睡眠相关问题和慢性疼痛的共同出现。未来的研究应该调查医用大麻使用与其他临床问题（如 PTSD 症状、睡眠、疼痛）随时间的相互关系，以及医用大麻使用对治疗参与和反应的潜在影响。
